Biotech Growth N V - Jun 30, 2023 Form 4 Insider Report for Black Diamond Therapeutics, Inc. (BDTX)

Role
10%+ Owner
Signature
/s/Ivo Betschart
Stock symbol
BDTX
Transactions as of
Jun 30, 2023
Transactions value $
$5,000,000
Form type
4
Date filed
7/3/2023, 03:36 PM
Previous filing
Jun 29, 2023
Next filing
Oct 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDTX Common Stock Purchase $5M +1M +14.05% $5.00 8.12M Jun 30, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Growth N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Black Diamond Therapeutics, Inc. held directly or indirectly by Biotech Growth N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Growth N.V.